Companies

Silence Therapeutics plc (SLN) SEC filings

CIK 0001479615 · Pharmaceutical Preparations (SIC 2834) · Nasdaq, OTC · incorporated in X0

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Revenue (USD)55900021.7 M
Net income (USD)-50.3 M
Diluted EPS (USD/shares)-0.63-0.49

Latest filings

FiledFormDescriptionPeriod
2026-10-19DEFA14ADEFA14A
2026-10-19DEFA14ADEFA14A
2026-10-198-K8-K items 1.01,7.01,9.012026-10-18
2026-10-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-10-13SCHEDULE 13GSCHEDULE 13G
2026-08-13SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-134OWNERSHIP DOCUMENT2026-08-10
2026-08-128-K8-K items 1.01,8.01,9.012026-08-10
2026-08-12424B5424B5
2026-08-11S-3MEFS-3MEF
2026-08-10424B5424B5
2026-08-108-K8-K items 7.01,8.01,9.012026-08-10
2026-08-1010-Q10-Q2026-06-30
2026-08-108-K8-K items 2.02,9.012026-08-10
2026-07-168-K/A8-K/A items 5.022026-07-10
2026-07-08SCHEDULE 13D/ASCHEDULE 13D/A
2026-07-074OWNERSHIP DOCUMENT2026-06-29
2026-06-238-K8-K items 7.01,9.012026-06-23
2026-06-168-K8-K items 5.072026-06-16
2026-06-118-K8-K items 8.01,9.012026-06-11
2026-05-27EFFECTEFFECT items ,,
2026-05-27424B5424B5
2026-05-22CORRESPCORRESP
2026-05-22UPLOADUPLOAD

Forms on file (last 1,000): 6-K 67, 4 42, 8-K 21, SC 13G/A 12, SC 13G 11, 3 10, EFFECT 10, UPLOAD 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=SLN (0.002 USD), /gw/filings/filings?ticker=SLN&form=8-K, /gw/filings/facts?ticker=SLN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange